Literature DB >> 22960443

The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Erin M Miller1, Francois Pomerleau, Peter Huettl, Vivienne A Russell, Greg A Gerhardt, Paul E A Glaser.   

Abstract

The most widely used animal model of attention-deficit/hyperactivity disorder (ADHD) is the spontaneously hypertensive rat (SHR/NCrl), which best represents the combined subtype (ADHD-C). Recent evidence has revealed that a progenitor strain, the Wistar Kyoto from Charles River Laboratories (WKY/NCrl), is useful as a model of the inattentive subtype (ADHD-PI) and the Wistar Kyoto from Harlan Laboratories (WKY/NHsd) and the Sprague Dawley (SD) have been suggested as controls. Dopamine (DA) dysfunction in the striatum (Str) and nucleus accumbens core (NAc) is thought to play a significant role in the pathophysiology of ADHD but data obtained with the SHR is equivocal. Using high-speed chronoamperometric recordings with carbon fiber microelectrodes, we found that the SHR/NCrl displayed decreased KCl-evoked DA release versus the WKY/NCrl model of ADHD-PI in the dorsal Str. The WKY/NCrl and the WKY/NHsd control did not differ from each other; however, the control SD released less DA than the WKY/NCrl model of ADHD-PI in the dorsal Str and less than the control WKY/NHsd in the intermediate Str. The SHR/NCrl had faster DA uptake in the ventral Str and NAc versus both control strains, while the WKY/NCrl model of ADHD-PI exhibited faster DA uptake in the NAc versus the SD control. These results suggest that increased surface expression of DA transporters may explain the more rapid uptake of DA in the Str and NAc of these rodent models of ADHD.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960443      PMCID: PMC3485688          DOI: 10.1016/j.neuropharm.2012.08.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  84 in total

1.  A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission.

Authors:  Suhas A Kotecha; James N Oak; Michael F Jackson; Yael Perez; Beverley A Orser; Hubert H M Van Tol; John F MacDonald
Journal:  Neuron       Date:  2002-09-12       Impact factor: 17.173

2.  Nucleus accumbens lesions modulate the effects of methylphenidate.

Authors:  Adam Podet; Min J Lee; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-05-12       Impact factor: 4.077

3.  A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder.

Authors:  A Feigin; R Kurlan; M P McDermott; J Beach; T Dimitsopulos; C A Brower; L Chapieski; K Trinidad; P Como; J Jankovic
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

4.  Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD).

Authors:  Brent Alsop
Journal:  J Neurosci Methods       Date:  2006-12-16       Impact factor: 2.390

Review 5.  The dopamine transporter and attention-deficit/hyperactivity disorder.

Authors:  Bertha K Madras; Gregory M Miller; Alan J Fischman
Journal:  Biol Psychiatry       Date:  2005-01-05       Impact factor: 13.382

6.  Microdialysis probes alter presynaptic regulation of dopamine terminals in rat striatum.

Authors:  Yuexiang Wang; Adrian C Michael
Journal:  J Neurosci Methods       Date:  2012-04-21       Impact factor: 2.390

7.  The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.

Authors:  Y Simchon; A Weizman; M Rehavi
Journal:  Eur Neuropsychopharmacol       Date:  2010-05-20       Impact factor: 4.600

8.  Deprenyl in attention deficit associated with Tourette's syndrome.

Authors:  J Jankovic
Journal:  Arch Neurol       Date:  1993-03

Review 9.  The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.

Authors:  Klaus Henning Krause; Stefan H Dresel; Johanna Krause; Christian la Fougere; Manfred Ackenheil
Journal:  Neurosci Biobehav Rev       Date:  2003-11       Impact factor: 8.989

10.  Maternal separation affects dopamine transporter function in the spontaneously hypertensive rat: an in vivo electrochemical study.

Authors:  Jacqueline S Womersley; Jennifer H Hsieh; Lauriston A Kellaway; Greg A Gerhardt; Vivienne A Russell
Journal:  Behav Brain Funct       Date:  2011-12-01       Impact factor: 3.759

View more
  17 in total

1.  Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Greg A Gerhardt; Paul E A Glaser
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Validation of a method to assess ADHD-related impulsivity in animal models.

Authors:  Elizabeth Watterson; Gabriel J Mazur; Federico Sanabria
Journal:  J Neurosci Methods       Date:  2015-04-01       Impact factor: 2.390

3.  Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.

Authors:  Yukio Ago; Masato Umehara; Kosuke Higashino; Shigeru Hasebe; Kazumi Fujita; Kazuhiro Takuma; Toshio Matsuda
Journal:  Neurochem Res       Date:  2014-03-15       Impact factor: 3.996

4.  Neurotransmitter Release of Reprogrammed Cells Using Electrochemical Detection Methods.

Authors:  Andreas Heuer
Journal:  Methods Mol Biol       Date:  2021

5.  Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.

Authors:  Sucharita S Somkuwar; Kathleen M Kantak; Linda P Dwoskin
Journal:  J Neurosci Methods       Date:  2015-02-11       Impact factor: 2.390

6.  Sex-dependent changes in ADHD-like behaviors in juvenile rats following cortical dopamine depletion.

Authors:  Nadja Freund; Heather T MacGillivilray; Britta S Thompson; Jodi L Lukkes; Jessica J Stanis; Heather C Brenhouse; Susan L Andersen
Journal:  Behav Brain Res       Date:  2014-05-23       Impact factor: 3.332

7.  Polygenic Risk Score-Derived Subcortical Connectivity Mediates Attention-Deficit/Hyperactivity Disorder Diagnosis.

Authors:  Robert J M Hermosillo; Michael A Mooney; Eric Fezcko; Eric Earl; Mollie Marr; Darrick Sturgeon; Anders Perrone; Oscar Miranda Dominguez; Stephen V Faraone; Beth Wilmot; Joel T Nigg; Damien A Fair
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-12-13

8.  HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy.

Authors:  Kalpana J Kallianpur; Victor G Valcour; Sukalaya Lerdlum; Edgar Busovaca; Melissa Agsalda; Pasiri Sithinamsuwan; Thep Chalermchai; James L K Fletcher; Somporn Tipsuk; Cecilia M Shikuma; Bruce T Shiramizu; Jintanat Ananworanich
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

9.  Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.

Authors:  S S Somkuwar; K M Kantak; M T Bardo; L P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2015-12-02       Impact factor: 3.533

10.  Imaging dopamine neurotransmission in live human brain.

Authors:  Rajendra D Badgaiyan
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.